抗VEGF肿瘤靶向治疗进展

被引：13

作者：

于顺江 ^{[1
,2
]}

机构：

[1] 北京大学第九临床学院

[2] 北京世纪坛医院肿瘤中心放疗科

来源：

癌症进展 | 2010年 / 8卷 / 02期

关键词：

VEGF; 血管形成; 靶向治疗; 联合治疗;

D O I：

暂无

中图分类号：

R730.54 [生物疗法];

学科分类号：

100103 [病原生物学];

摘要：

<正>随着分子生物学的发展,以作用于细胞表面受体和细胞内信号蛋白分子为靶点的治疗已进入肿瘤的临床治疗,这一类药物主要特点是特异性高,针对性强,毒副作用相对较低,已逐步被国内外肿瘤领域医师所认同。这类药物目前主要包括单抗类、小分子酪氨酸激酶抑制剂如抗血管生成制剂和小分子多靶点制剂。

引用

页码：175 / 179

页数：5

共 8 条

[1]

Bevacizumab: current indications and future development for management of solid tumors [J].

Jenab-Wolcott, Jenia ;

Giantonio, Bruce J. .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (04) :507-517

[2]

Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib [J].

Vroling, Laura ;

van der Veldt, Astrid A. M. ;

de Haas, Richard R. ;

Haanen, John B. A. G. ;

Schuurhuis, Gerrit Jan ;

Kuik, Dirk J. ;

van Cruijsen, Hester ;

Verheul, Henk M. W. ;

van den Eertwegh, Alfons J. M. ;

Hoekman, Klaas ;

Boven, Epie ;

van Hinsbergh, Victor W. M. ;

Broxterman, Henk J. .

ANGIOGENESIS, 2009, 12 (01) :69-79

[3]

Novel anti-angiogenic therapies for malignant gliomas [J].

Norden, Andrew D. ;

Drappatz, Jan ;

Wen, Patrick Y. .

LANCET NEUROLOGY, 2008, 7 (12) :1152-1160

[4]

Antiangiogenic agents for the treatment of glioblastoma [J].

Gerstner, Elizabeth R. ;

Duda, Dan G. ;

di Tomaso, Emmanuelle ;

Sorensen, Greg ;

Jain, Rakesh K. ;

Batchelor, Tracy T. .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (12) :1895-1908

[5]

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients [J].

Batchelor, Tracy T. ;

Sorensen, A. Gregory ;

di Tomaso, Emmanuelle ;

Zhang, Wei-Ting ;

Duda, Dan G. ;

Cohen, Kenneth S. ;

Kozak, Kevin R. ;

Cahill, Daniel P. ;

Chen, Poe-Jou ;

Zhu, Mingwang ;

Ancukiewicz, Marek ;

Mrugala, Maciej M. ;

Plotkin, Scott ;

Drappatz, Jan ;

Louis, David N. ;

Ivy, Percy ;

Scadden, David T. ;

Benner, Thomas ;

Loeffler, Jay S. ;

Wen, Patrick Y. ;

Jain, Rakesh K. .

CANCER CELL, 2007, 11 (01) :83-95

[6]

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial [J].

Demetri, George D. ;

van Oosterom, Allan T. ;

Garrett, Christopher R. ;

Blackstein, Martin E. ;

Shah, Manisha H. ;

Verweij, Jaap ;

McArthur, Grant ;

Judson, Ian R. ;

Heinrich, Michael C. ;

Morgan, Jeffrey A. ;

Desai, Jayesh ;

D Fletcher, Christopher ;

George, Suzanne ;

Bello, Carlo L. ;

Huang, Xin ;

Baum, Charles M. ;

Casali, Paolo G. .

LANCET, 2006, 368 (9544) :1329-1338

[7]

Mechanisms of Action of Bevacizumab as a Component of Therapy for Metastatic Colorectal Cancer.[J].Lee M. Ellis.Seminars in Oncology.2006,

[8]

Future Directions in Vascular Endothelial Growth Factor–Targeted Therapy for Metastatic Colorectal Cancer.[J].Axel Grothey.Seminars in Oncology.2006,

← 1 →